IRCT2013041311356N2已完成未知
Comparison of Effects Metformin and pioGlutazon on Serum Osteoprotegerin and adiponectin in Patients with Type 2 diabetes in clinic of Imam Khomeini 2013
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30 years 至 70 years（—）
- 性别
- All
入选标准
- •determination of Type 2 diabetes with ADA criteria (FBS=126 or HbA1C=6.5) and patients with newly diagnosed diabetes. Exclusion criteria: history of hurt failure; Creatine > 1.5 mg/dl; liver failure; history of malignancy and being treated with insulin or other glucose-lowering drugs.
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Differential effects of metformin and pioglithazone on hs-CRP in patients with type II DM.diabetes mellitus II.non-insulin-dependent diabetes mellitusIRCT201109067482N1Qazvin University of Medical Sciences40
已完成
不适用
Comparative Efficacy of Pioglitazone and Metformin in Glucose Variability in Type 2 Diabetestype 2 diabetesJPRN-UMIN000001891Jikei University School of Medicine20
招募中
1 期
Comparison of the effect Of Metformin and Pioglitazone on hypertriglyceridemia(Dyslipidemia)Condition 1: Hypertriglyceridemia. Condition 2: Metabolic syndrom.Pure hyperglyceridemiaMetabolic syndromeE78.1E88.81IRCT20230618058524N1Islamic Azad University68
已完成
不适用
Effect of metformin, pioglitazone and vitaminE E in patients with non-alcoholic fatty liver diseasenon-alcoholic fatty liver disease.Fatty (change of) liver, not elsewhere classifiedIRCT2016010411991N3Vice chancellor for research,Kermanshah University of Medical Sciences93
已完成
4 期
To study the differences in the effects of various drugs in patients suffering from metabolic syndrome, which is a cluster of conditions such as obesity, increased blood pressure and disordered cholesterol levels that increases the risk of heart diseases, diabetes and stroke.CTRI/2014/10/005139Department of Pharmacology140